Why Parents Hesitate Before Seeking Mental-Health Expertise
Parents who have no problem making a doctor's appointment when their children have a cough, sneeze, or sniffle appear to be resistant when it comes to mental health.
Parents Magazine and the Child Mind Institute conducted a new survey to find out why parents hesitate before getting mental-health expertise for their children.
"If your child has a fever you take them to the doctor, if your child has an emotional pain, it should be the same thing," said Liz Vaccariello, the editor-in-chief of Parents Magazine, in an interview with Cheddar on Tuesday.
A new survey of about 400 parents in the United States found 62% would wait more than five weeks to get their children help with a mood or behavior disorder.
Of the families that said they would think twice before pursuing treatment options, most (83%) said they try to avoid an overreaction and would rather wait to see if symptoms resolve on their own. Other reasons include the perceived cost of mental-health care and the fear that their children would be labelled mentally ill.
"All of these are myths and we're trying to overcome that," said Vaccariello.
She said parents should be vigilant about monitoring their children's behavior for potential warning signs. Doctors describe these potential symptoms as "pink flags" instead of "red flags" because they're often subtle indicators of mental illness.
Vaccariello said symptoms include sleep disturbances, obsessive thoughts, and debilitating fears.
"It's one thing to be scared of a bee, it's another thing to be terrified to go outside because you don't want to be stung by a bee," she said.
There are fewer than 9,000 clinical child psychiatrists in the United States, but Vaccariello said parents can also reach out to child psychologists, therapists, and school counselors.
"Even something like that can be helpful and healing for the whole family," she said.
For full interview, [click here](https://cheddar.com/videos/why-do-parents-wait-to-seek-help-on-mental-health-issues).
Carlo and Baker cover the latest data showing the Omicron wave has likely started, Pfizer's Covid pill, Jan. 6 and a box office rescue attempt courtesy of Spider-Man.
Upward Farms is an indoor vertical farming company on a mission to heal our broken food system and reconnect consumers with organic locally-grown food. The Brooklyn-based company uses its controlled environment farms to grow organic leafy greens, which are sold at whole foods markets in New York City. Upward Farms co-founder and CEO Jason Green joined Cheddar Climate to discuss.
One of the biggest hurdles when it comes to widespread electric vehicle adoption is consumer hesitation about their ability to keep their EV charged if they take a longer trip outside of their locality. Now, electric companies nationwide are teaming up as part of a coalition to build out a network of EV charging stations spanning major U.S. travel corridors. Kellen Schefter, director of electric transportation at the Edison Electric Institute, joins Cheddar Climate to discuss the coalition's plans, how drivers can compare fueling up with gas to recharging an EV on a long trip, how the charging network will be funded, and more.
As more states begin to legalize recreational marijuana, there's a growing interest in legalizing cannabis cultivation. As the rise in cannabis farms expands across the U.S., more research is being done to examine its impact on the planet. Michael Katz, executive director at Mendocino Cannabis Alliance, joins Cheddar News to talk about the carbon footprint of cannabis farms.
Blue Origin launched its third manned mission over the weekend with 'Good Morning America' host Michael Strahan and Laura Shepard Churchley, daughter of astronaut Alan Shepard on board, alongside several Blue Origin investors.
This comes after the spaceflight firm launched two successful missions to the edge of space earlier this year. How will these missions set up Blue Origin for success as it competes with SpaceX and other companies for space tourism domination and more? Joey Roulette, space reporter at The New York Times, joins Cheddar News' Closing Bell to discuss.
Mina Makar, senior vice president of respiratory and immunology, Astrazeneca, joined Cheddar to discuss the FDA's decision to give emergency use authorization to the pharma giant's COVID-19 antibody treatment called Evusheld for immunocompromised patients For about 2 percent of the U.S. Makar noted that the injection is supposed to provide antibody protection for those who can't generate their own adequate immune response via the vaccines for a minimum of six months, though long-term trials are underway.
The pandemic has forced corporate America to reshape itself to adapt, including onboarding doctors as chief medical officers to help maintain the health and safety of staff. Dr. Geeta Nayyar, chief medical officer at Salesforce, joined Cheddar to break down her role and how it has become relevant and necessary in the evolving workplace. "Every business today is now in the business of healthcare," she said. "It is a priority to empower employees to then serve your customers."
Jonathan Adler, Law Professor at Case Western Reserve University, joined Wake Up With Cheddar to discuss Tuesday's ruling and provide legal context to recent battles over vaccine mandates.
Carlo and Baker wrap up the week talking about the Biden economic boom that no one seems to notice, a verdict in the Jussie Smollett case, the first Starbucks union in America and the pleasures of the "dude nod."
